{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T14:56:29Z","timestamp":1768920989813,"version":"3.49.0"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.ahj.2018.11.001","type":"journal-article","created":{"date-parts":[[2018,11,23]],"date-time":"2018-11-23T21:35:32Z","timestamp":1543008932000},"page":"91-99","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"C","title":["The prognostic value of various biomarkers in adults with pulmonary hypertension; a multi-biomarker approach"],"prefix":"10.1016","volume":"208","author":[{"given":"Laurie W.","family":"Geenen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vivan J.M.","family":"Baggen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Koudstaal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karin A.","family":"Boomars","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jannet A.","family":"Eindhoven","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Boersma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jolien W.","family":"Roos-Hesselink","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annemien E.","family":"van den Bosch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.ahj.2018.11.001_bb0005","doi-asserted-by":"crossref","first-page":"343","DOI":"10.7326\/0003-4819-115-5-343","article-title":"Survival in patients with primary pulmonary hypertension. Results from a national prospective registry","volume":"115","author":"D'Alonzo","year":"1991","journal-title":"Ann Intern Med"},{"issue":"25 Suppl","key":"10.1016\/j.ahj.2018.11.001_bb0010","doi-asserted-by":"crossref","first-page":"D22","DOI":"10.1016\/j.jacc.2013.10.027","article-title":"Right heart adaptation to pulmonary arterial hypertension: physiology and pathobiology","volume":"62","author":"Vonk-Noordegraaf","year":"2013","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.ahj.2018.11.001_bb0015","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1183\/09031936.00078411","article-title":"ASPIRE registry: assessing the Spectrum of Pulmonary hypertension Identified at a REferral centre","volume":"39","author":"Hurdman","year":"2012","journal-title":"Eur Respir J"},{"issue":"4","key":"10.1016\/j.ahj.2018.11.001_bb0020","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1183\/13993003.01032-2015","volume":"46","author":"Galie","year":"2015","journal-title":"Eur Respir J"},{"issue":"4","key":"10.1016\/j.ahj.2018.11.001_bb0025","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.amjcard.2006.02.061","article-title":"N-terminal pro-B-type natriuretic peptide as an indicator of disease severity in a heterogeneous group of patients with chronic precapillary pulmonary hypertension","volume":"98","author":"Andreassen","year":"2006","journal-title":"Am J Cardiol"},{"issue":"7","key":"10.1016\/j.ahj.2018.11.001_bb0030","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1161\/01.CIR.0000084544.54513.E2","article-title":"Detectable serum cardiac troponin T as a marker of poor prognosis among patients with chronic precapillary pulmonary hypertension","volume":"108","author":"Torbicki","year":"2003","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.ahj.2018.11.001_bb0035","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.healun.2014.12.005","article-title":"Circulating biomarkers in pulmonary arterial hypertension: update and future direction","volume":"34","author":"Pezzuto","year":"2015","journal-title":"J Heart Lung Transplant"},{"issue":"6 Suppl","key":"10.1016\/j.ahj.2018.11.001_bb0040","doi-asserted-by":"crossref","first-page":"32S","DOI":"10.1016\/j.amjcard.2012.06.014","article-title":"The potential of biomarkers in pulmonary arterial hypertension","volume":"110","author":"Cracowski","year":"2012","journal-title":"Am J Cardiol"},{"issue":"11","key":"10.1016\/j.ahj.2018.11.001_bb0045","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/j.hlc.2016.12.012","article-title":"Galectin-3 Levels Are Elevated and Predictive of Mortality in Pulmonary Hypertension","volume":"26","author":"Mazurek","year":"2017","journal-title":"Heart Lung Circ"},{"issue":"6","key":"10.1016\/j.ahj.2018.11.001_bb0050","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.amjcard.2009.05.016","article-title":"Usefulness of red cell distribution width as a prognostic marker in pulmonary hypertension","volume":"104","author":"Hampole","year":"2009","journal-title":"Am J Cardiol"},{"issue":"13","key":"10.1016\/j.ahj.2018.11.001_bb0055","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1136\/hrt.2011.224857","article-title":"Red cell distribution width outperforms other potential circulating biomarkers in predicting survival in idiopathic pulmonary arterial hypertension","volume":"97","author":"Rhodes","year":"2011","journal-title":"Heart"},{"issue":"14","key":"10.1016\/j.ahj.2018.11.001_bb0060","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/j.jacc.2008.12.038","article-title":"C-reactive protein: a new predictor of adverse outcome in pulmonary arterial hypertension","volume":"53","author":"Quarck","year":"2009","journal-title":"J Am Coll Cardiol"},{"issue":"25 Suppl","key":"10.1016\/j.ahj.2018.11.001_bb0065","doi-asserted-by":"crossref","first-page":"D34","DOI":"10.1016\/j.jacc.2013.10.029","article-title":"Updated clinical classification of pulmonary hypertension","volume":"62","author":"Simonneau","year":"2013","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.ahj.2018.11.001_bb0070","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/ehjci\/jev014","article-title":"Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"16","author":"Lang","year":"2015","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"6","key":"10.1016\/j.ahj.2018.11.001_bb0075","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.jcmg.2015.12.015","article-title":"MR and CT Imaging for the Evaluation of Pulmonary Hypertension","volume":"9","author":"Freed","year":"2016","journal-title":"JACC Cardiovasc Imaging"},{"issue":"2","key":"10.1016\/j.ahj.2018.11.001_bb0080","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1378\/chest.11-0676","article-title":"The REVEAL Registry risk score calculator in patients newly diagnosed with pulmonary arterial hypertension","volume":"141","author":"Benza","year":"2012","journal-title":"Chest"},{"issue":"19","key":"10.1016\/j.ahj.2018.11.001_bb0085","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1161\/01.CIR.0000147181.65298.4D","article-title":"Galectin-3 marks activated macrophages in failure-prone hypertrophied hearts and contributes to cardiac dysfunction","volume":"110","author":"Sharma","year":"2004","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.ahj.2018.11.001_bb0090","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1007\/s00380-015-0691-z","article-title":"Galectin-3 levels are associated with right ventricular functional and morphologic changes in pulmonary arterial hypertension","volume":"31","author":"Fenster","year":"2016","journal-title":"Heart Vessel"},{"issue":"5","key":"10.1016\/j.ahj.2018.11.001_bb0095","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1136\/heartjnl-2015-308365","article-title":"Galectin-3 and aldosterone as potential tandem biomarkers in pulmonary arterial hypertension","volume":"102","author":"Calvier","year":"2016","journal-title":"Heart"},{"issue":"1","key":"10.1016\/j.ahj.2018.11.001_bb0100","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.cardiores.2007.03.007","article-title":"The microenvironment can shift erythrocytes from a friendly to a harmful behavior: pathogenetic implications for vascular diseases","volume":"75","author":"Minetti","year":"2007","journal-title":"Cardiovasc Res"},{"issue":"3","key":"10.1016\/j.ahj.2018.11.001_bb0105","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.cardfail.2009.11.003","article-title":"Validation and potential mechanisms of red cell distribution width as a prognostic marker in heart failure","volume":"16","author":"Allen","year":"2010","journal-title":"J Card Fail"},{"issue":"4","key":"10.1016\/j.ahj.2018.11.001_bb0110","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.healun.2017.11.006","article-title":"REVEAL risk scores applied to riociguat-treated patients in PATENT-2: Impact of changes in risk score on survival","volume":"37","author":"Benza","year":"2018","journal-title":"J Heart Lung Transplant"},{"issue":"9","key":"10.1016\/j.ahj.2018.11.001_bb0115","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1056\/NEJMoa1413687","article-title":"Initial use of ambrisentan plus tadalafil in pulmonary arterial hypertension","volume":"373","author":"Galie","year":"2015","journal-title":"N Engl J Med"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870318303089?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870318303089?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T06:02:04Z","timestamp":1757570524000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870318303089"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":23,"alternative-id":["S0002870318303089"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2018.11.001","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The prognostic value of various biomarkers in adults with pulmonary hypertension; a multi-biomarker approach","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2018.11.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}